DarDoc Research

GLP-1 Trial & Approval Tracker

Compare GLP-1 trial arms

Compare results within a trial or inspect the context behind results from different studies.

STEP 5

Wegovy injection

Without diabetes · 104 weeks · n=304

Double-blind, placebo-controlled. Both groups received behavioural support. Treatment-policy analysis.

Mean body weight change at 104 weeks
  • Semaglutide 2.4 mg−15.2%
  • Placebo−2.6%

A direct comparison uses arms from the same trial. Switch to Two studies to inspect the context behind separate results.